Tags

Type your tag names separated by a space and hit enter

Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis.
J Am Acad Dermatol. 2014 Feb; 70(2):338-51.JA

Abstract

Atopic dermatitis (AD) is a chronic, pruritic, inflammatory dermatosis that affects up to 25% of children and 2% to 3% of adults. This guideline addresses important clinical questions that arise in the management and care of AD, providing updated and expanded recommendations based on the available evidence. In this first of 4 sections, methods for the diagnosis and monitoring of disease, outcomes measures for assessment, and common clinical associations that affect patients with AD are discussed. Known risk factors for the development of disease are also reviewed.

Links

PMC Free PDF

Authors+Show Affiliations

Eichenfield LF
Division of Pediatric and Adolescent Dermatology, Rady Children's Hospital San Diego, San Diego, California.
Tom WL
Division of Pediatric and Adolescent Dermatology, Rady Children's Hospital San Diego, San Diego, California.
Chamlin SL
Department of Dermatology, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.
Feldman SR
Department of Dermatology, Wake Forest University Health Sciences, Winston-Salem, North Carolina.
Hanifin JM
Department of Dermatology, Oregon Health and Science University, Portland, Oregon.
Simpson EL
Department of Dermatology, Oregon Health and Science University, Portland, Oregon.
Berger TG
Department of Dermatology, University of California San Francisco, San Francisco, California.
Bergman JN
Department of Dermatology and Skin Science, University of British Columbia, Vancouver, British Columbia, Canada.
Cohen DE
Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York.
Cooper KD
Department of Dermatology, Case Western University, Cleveland, Ohio.
Cordoro KM
Department of Dermatology, University of California San Francisco, San Francisco, California.
Davis DM
Department of Dermatology, Mayo Clinic, Rochester, Minnesota.
Krol A
Department of Dermatology, Oregon Health and Science University, Portland, Oregon.
Margolis DJ
Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania.
Paller AS
Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Schwarzenberger K
Division of Dermatology, Fletcher Allen Health Care, Burlington, Vermont.
Silverman RA
Private practice, Fairfax, Virginia.
Williams HC
Centre of Evidence-Based Dermatology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.
Elmets CA
Department of Dermatology, University of Alabama at Birmingham, Birmingham, Alabama.
Block J
National Eczema Association, San Rafael, California.
Harrod CG
American Academy of Dermatology, Schaumburg, Illinois.
Smith Begolka W
American Academy of Dermatology, Schaumburg, Illinois. Electronic address: wsmithbegolka@aad.org.
Sidbury R
Department of Dermatology, Seattle Children's Hospital, Seattle, Washington.

MeSH

AdolescentAdultAge FactorsBiomarkersChildChronic DiseaseComorbidityDermatitis, AtopicEvidence-Based MedicineFemaleFilaggrin ProteinsHumansMalePhysical ExaminationPractice Guidelines as TopicPrognosisQuality of LifeRisk AssessmentSeverity of Illness IndexYoung Adult

Pub Type(s)

Journal Article
Research Support, N.I.H., Extramural
Review

Language

eng

PubMed ID

24290431

Clinical Trial Links

A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists
The Role of Bathing Additives in the Treatment of Pediatric Atopic Dermatitis
Baricitinib Versus Azathioprine in Patients With Moderate-to-Severe Atopic Dermatitis

Citation

Eichenfield, Lawrence F., et al. "Guidelines of Care for the Management of Atopic Dermatitis: Section 1. Diagnosis and Assessment of Atopic Dermatitis." Journal of the American Academy of Dermatology, vol. 70, no. 2, 2014, pp. 338-51.
Eichenfield LF, Tom WL, Chamlin SL, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014;70(2):338-51.
Eichenfield, L. F., Tom, W. L., Chamlin, S. L., Feldman, S. R., Hanifin, J. M., Simpson, E. L., Berger, T. G., Bergman, J. N., Cohen, D. E., Cooper, K. D., Cordoro, K. M., Davis, D. M., Krol, A., Margolis, D. J., Paller, A. S., Schwarzenberger, K., Silverman, R. A., Williams, H. C., Elmets, C. A., ... Sidbury, R. (2014). Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. Journal of the American Academy of Dermatology, 70(2), 338-51. https://doi.org/10.1016/j.jaad.2013.10.010
Eichenfield LF, et al. Guidelines of Care for the Management of Atopic Dermatitis: Section 1. Diagnosis and Assessment of Atopic Dermatitis. J Am Acad Dermatol. 2014;70(2):338-51. PubMed PMID: 24290431.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. AU - Eichenfield,Lawrence F, AU - Tom,Wynnis L, AU - Chamlin,Sarah L, AU - Feldman,Steven R, AU - Hanifin,Jon M, AU - Simpson,Eric L, AU - Berger,Timothy G, AU - Bergman,James N, AU - Cohen,David E, AU - Cooper,Kevin D, AU - Cordoro,Kelly M, AU - Davis,Dawn M, AU - Krol,Alfons, AU - Margolis,David J, AU - Paller,Amy S, AU - Schwarzenberger,Kathryn, AU - Silverman,Robert A, AU - Williams,Hywel C, AU - Elmets,Craig A, AU - Block,Julie, AU - Harrod,Christopher G, AU - Smith Begolka,Wendy, AU - Sidbury,Robert, Y1 - 2013/11/27/ PY - 2013/08/17/received PY - 2013/10/03/revised PY - 2013/10/05/accepted PY - 2013/12/3/entrez PY - 2013/12/3/pubmed PY - 2014/3/19/medline KW - AAD KW - AD KW - ADHD KW - American Academy of Dermatology KW - CDLQI KW - Children's Dermatology Life Quality Index KW - DFI KW - DLQI KW - Dermatitis Family Impact KW - Dermatology Life Quality Index KW - EASI KW - Eczema Area and Severity Index KW - FLG KW - GREAT KW - Global Resource for Eczema Trials KW - IGA KW - IL KW - ISAAC KW - IgE KW - International Study of Asthma and Allergies in Childhood KW - Investigator's Global Assessment KW - MDC KW - POEM KW - Patient-Oriented Eczema Measure KW - SASSAD KW - SCORAD KW - SCORing Atopic Dermatitis KW - SORT KW - Six Area, Six Sign Atopic Dermatitis KW - TARC KW - TISS KW - Three-Item Severity Scale KW - UK KW - United Kingdom KW - assessment scales KW - atopic dermatitis KW - attention deficit hyperactivity disorder KW - biomarkers KW - clinical associations KW - criteria KW - diagnosis KW - filaggrin KW - immunoglobulin E KW - interleukin KW - macrophage-derived chemoattractant KW - risk factors KW - strength of recommendation taxonomy KW - thymus and activation-regulated chemokine SP - 338 EP - 51 JF - Journal of the American Academy of Dermatology JO - J Am Acad Dermatol VL - 70 IS - 2 N2 - Atopic dermatitis (AD) is a chronic, pruritic, inflammatory dermatosis that affects up to 25% of children and 2% to 3% of adults. This guideline addresses important clinical questions that arise in the management and care of AD, providing updated and expanded recommendations based on the available evidence. In this first of 4 sections, methods for the diagnosis and monitoring of disease, outcomes measures for assessment, and common clinical associations that affect patients with AD are discussed. Known risk factors for the development of disease are also reviewed. SN - 1097-6787 UR - https://www.unboundmedicine.com/medline/citation/24290431/full_citation DB - PRIME DP - Unbound Medicine ER -
High [↓449 ↑175]

Related Citations

    More

    Others Viewed